Silence Therapeutics plc – LSE:SLN.L
Silence Therapeutics stock price today
Silence Therapeutics stock price monthly change
Silence Therapeutics stock price quarterly change
Silence Therapeutics stock price yearly change
Silence Therapeutics key metrics
Market Cap | N/A |
Enterprise value | 47.93B |
P/E | -0.11 |
EV/Sales | 15189.97 |
EV/EBITDA | -4035.99 |
Price/Sales | 152.12 |
Price/Book | 29.34 |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -314.61% |
Oper. margin | -389.23% |
Gross margin | 34.98% |
EBIT margin | -389.23% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSilence Therapeutics stock price history
Silence Therapeutics stock forecast
Silence Therapeutics financial statements
| Jun 2015 | 0 | 0 | |
|---|---|---|---|
| Jun 2017 | 0 | 0 | |
| Jun 2018 | 0 | 0 | |
| Sep 2021 | 3.15M | -9.92M | -314.61% |
| Jun 2020 | 100087000 | 72.46M | 72.4% |
|---|---|---|---|
| Dec 2020 | 85971000 | 76.91M | 89.46% |
| Jun 2021 | 100725000 | 77.05M | 76.5% |
| Sep 2021 | 92755000 | 76.39M | 82.36% |
| Jan 2019 | 431.75K | -3.75M | 1.31M |
|---|---|---|---|
| Mar 2019 | 431.75K | -3.75M | 1.31M |
| Jun 2019 | 431.75K | -3.75M | 1.31M |
| Sep 2021 | -4.92M | 4.67M | 425K |
Silence Therapeutics alternative data
| Aug 2023 | 65 |
|---|---|
| Sep 2023 | 65 |
| Oct 2023 | 65 |
| Nov 2023 | 65 |
| Dec 2023 | 65 |
| Jan 2024 | 65 |
| Feb 2024 | 65 |
| Mar 2024 | 65 |
| Apr 2024 | 65 |
| May 2024 | 65 |
| Jun 2024 | 65 |
| Jul 2024 | 65 |
Silence Therapeutics other data
-
What's the price of Silence Therapeutics stock today?
One share of Silence Therapeutics stock can currently be purchased for approximately $535.
-
When is Silence Therapeutics's next earnings date?
Unfortunately, Silence Therapeutics's (SLN.L) next earnings date is currently unknown.
-
Does Silence Therapeutics pay dividends?
No, Silence Therapeutics does not pay dividends.
-
What is Silence Therapeutics's stock symbol?
Silence Therapeutics plc is traded on the LSE under the ticker symbol "SLN.L".
-
What is Silence Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Silence Therapeutics?
Shares of Silence Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Silence Therapeutics have?
As Jul 2024, Silence Therapeutics employs 65 workers.
-
When Silence Therapeutics went public?
Silence Therapeutics plc is publicly traded company for more then 15 years since IPO on 5 Jan 2010.
-
What is Silence Therapeutics's official website?
The official website for Silence Therapeutics is silence-therapeutics.com.
-
How can i contact Silence Therapeutics?
Silence Therapeutics can be reached via phone at +44 20 3457 6900.
Silence Therapeutics company profile:
Silence Therapeutics plc
silence-therapeutics.comLSE
65
Biotechnology
Healthcare
Silence Therapeutics plc focuses on the discovery, development, and delivery of novel RNA therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company designs short interfering RNA (siRNA) molecules that trigger the RNAi pathway and mediate the degradation of specific target messenger RNAs. It is developing various product candidates, including SLN124 for the treatment of iron overload disorders; SLN360 for the cardiovascular disease with high lipoprotein; and SLN500 for the treatment of complement-mediated diseases. Silence Therapeutics plc has a strategic collaboration with AstraZeneca to discover, develop, and commercialize small interfering RNA therapeutics for the treatment of cardiovascular, renal, metabolic, and respiratory diseases; and collaboration with Genomics England Limited. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc is headquartered in London, the United Kingdom.
LONDON, W14 8TH
:
ISIN: GB00B9GTXM62
CUSIP: G8128Y157
